BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12925383)

  • 1. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases.
    Hairston BR; Davis MD; Gibson LE; Drage LA
    Arch Dermatol; 2003 Aug; 139(8):987-90. PubMed ID: 12925383
    [No Abstract]   [Full Text] [Related]  

  • 2. Livedoid vasculopathy in a pediatric patient with elevated lipoprotein(a) levels: prompt response to continuous low-molecular-weight heparin.
    Goerge T; Weishaupt C; Metze D; Nowak-Göttl U; Sunderkötter C; Steinhoff M; Schneider SW
    Arch Dermatol; 2010 Aug; 146(8):927-8. PubMed ID: 20713839
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
    Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What was your diagnosis at first glance... livedoid vasculopathy].
    Hirschel V
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1439. PubMed ID: 23986912
    [No Abstract]   [Full Text] [Related]  

  • 5. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe livedoid vasculopathy associated with antiphosphatidylserine-prothrombin complex antibody successfully treated with warfarin.
    Noda S; Asano Y; Yamazaki M; Ichimura Y; Tamaki Z; Takekoshi T; Sugaya M; Sato S
    Arch Dermatol; 2011 May; 147(5):621-3. PubMed ID: 21576587
    [No Abstract]   [Full Text] [Related]  

  • 8. Mononeuropathy multiplex in association with livedoid vasculitis.
    Toth C; Trotter M; Clark A; Zochodne D
    Muscle Nerve; 2003 Nov; 28(5):634-9. PubMed ID: 14571469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin for recurrent cutaneous necrotizing eosinophilic vasculitis.
    Tanglertsampan C; Tantikun N; Noppakun N; Pinyopornpanit V
    J Med Assoc Thai; 2007 Jun; 90(6):1180-2. PubMed ID: 17624214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficult management of livedoid vasculopathy.
    Francès C; Barete S
    Arch Dermatol; 2004 Aug; 140(8):1011. PubMed ID: 15313824
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livedoid vasculitis responding to PUVA therapy.
    Lee JH; Choi HJ; Kim SM; Hann SK; Park YK
    Int J Dermatol; 2001 Feb; 40(2):153-7. PubMed ID: 11328402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
    Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
    Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisole-adulterated cocaine: a distinctive clinicopathologic presentation.
    Jenkins J; Babu K; Hsu-Hung E; Robinson-Bostom L; Kroumpouzos G
    J Am Acad Dermatol; 2011 Jul; 65(1):e14-6. PubMed ID: 21679797
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of livedoid vasculopathy with short-cycle intravenous immunoglobulins.
    Pitarch G; Rodríguez-Serna M; Torrijos A; Oliver V; Fortea JM
    Acta Derm Venereol; 2005; 85(4):374-5. PubMed ID: 16191872
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of anticoagulation therapy with low molecular weight heparin in acute pancreatitis].
    Jiao HB; Qiao Z; Tan XL; Du JD; Fei Y; Wang DD; Li JY; Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):712-4. PubMed ID: 15585141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase polymorphism associated with moderate hyperhomocysteinaemia in a patient with livedo vasculopathy: treatment with vitamin supplementation and low molecular weight heparin.
    Rampf J; Sunderkötter C; Hirschfeld G; Scharffetter-Kochanek K; Weiss JM
    Br J Dermatol; 2006 Oct; 155(4):850-2. PubMed ID: 16965447
    [No Abstract]   [Full Text] [Related]  

  • 20. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
    Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
    Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.